FDA Adds More Priority Vouchers, Including for Orforglipron, Wegovy
- November 07, 2025
The FDA announced November 6 a second batch of six awardees for its newly launched National Priority Voucher program, which is expected to slash review times for new drugs from the current ten to 12 months to one to two months.
ARTICLE TAGS
You must be logged in to access this content.